Induced pluripotent stem cell (iPSC) models of bipolar disorder

K. Sue O'Shea; Melvin G. McInnis

doi:10.1038/npp.2014.221

Induced pluripotent stem cell (iPSC) models of bipolar disorder

K. Sue O'Shea, Melvin G. McInnis

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	248-249
Number of pages	2
Journal	Neuropsychopharmacology
Volume	40
Issue number	1
DOIs	https://doi.org/10.1038/npp.2014.221
State	Published - Jan 1 2015

ASJC Scopus subject areas

Pharmacology
Psychiatry and Mental health

Access to Document

10.1038/npp.2014.221

Cite this

@article{0d8d628052cd47b6be1c8a61653d9390,

title = "Induced pluripotent stem cell (iPSC) models of bipolar disorder",

author = "O'Shea, {K. Sue} and McInnis, {Melvin G.}",

note = "Funding Information: Dr Gillan and Professor Sahakian are affiliates of the Behavioural and Clin ical Neuroscience Institute, which is supported by a joint award from the Medical Research Council and Well come Trust (G00001354). Dr Gillan is supported by a Sir Henry Wellcome Postdoctoral Fellowship (101521/Z/12/Z). Professor Barbara Sahakian consults for Cambridge Cognition, Servier and Lundbeck. She holds a grant from Janssen/J&J. She has share options in Cambridge Cognition. Much of this research was funded by a Wellcome Trust grant awarded to T.W. Robbins, B.J. Everitt, A.C. Roberts, J.W. Dalley and B.J. Sahakian (089589/Z/09/Z). Funding Information: This work is supported by the HC Prechter Bipolar Research Fund and Steven Schwartzberg Memorial Fund at the University of Michigan.",

year = "2015",

month = jan,

day = "1",

doi = "10.1038/npp.2014.221",

language = "English (US)",

volume = "40",

pages = "248--249",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Induced pluripotent stem cell (iPSC) models of bipolar disorder

AU - O'Shea, K. Sue

AU - McInnis, Melvin G.

N1 - Funding Information: Dr Gillan and Professor Sahakian are affiliates of the Behavioural and Clin ical Neuroscience Institute, which is supported by a joint award from the Medical Research Council and Well come Trust (G00001354). Dr Gillan is supported by a Sir Henry Wellcome Postdoctoral Fellowship (101521/Z/12/Z). Professor Barbara Sahakian consults for Cambridge Cognition, Servier and Lundbeck. She holds a grant from Janssen/J&J. She has share options in Cambridge Cognition. Much of this research was funded by a Wellcome Trust grant awarded to T.W. Robbins, B.J. Everitt, A.C. Roberts, J.W. Dalley and B.J. Sahakian (089589/Z/09/Z). Funding Information: This work is supported by the HC Prechter Bipolar Research Fund and Steven Schwartzberg Memorial Fund at the University of Michigan.

PY - 2015/1/1

Y1 - 2015/1/1

UR - http://www.scopus.com/inward/record.url?scp=84927168814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927168814&partnerID=8YFLogxK

U2 - 10.1038/npp.2014.221

DO - 10.1038/npp.2014.221

M3 - Comment/debate

C2 - 25482177

AN - SCOPUS:84927168814

SN - 0893-133X

VL - 40

SP - 248

EP - 249

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

IS - 1

ER -

Induced pluripotent stem cell (iPSC) models of bipolar disorder

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this